Laboratorios Richmond SACIF (RICH) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Laboratorios Richmond SACIF (RICH) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AR$202.02 Million ≈ $146.18K USD) by net assets (AR$72.73 Billion ≈ $52.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Laboratorios Richmond SACIF to measure how much of total assets are equity-financed.

Laboratorios Richmond SACIF - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Laboratorios Richmond SACIF's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Laboratorios Richmond SACIF (RICH) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Laboratorios Richmond SACIF Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Laboratorios Richmond SACIF ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd
KQ:307750
0.040x
Kelly Services B Inc
NASDAQ:KELYB
-0.026x
Rich Sparkle Holdings Limited Ordinary Shares
NASDAQ:ANPA
N/A
Seco/Warwick SA
WAR:SWG
-0.098x
Kumkang Kind
KO:014280
-0.005x
Bathurst Resources Ltd
AU:BRL
0.011x
Orior AG
SW:ORON
0.250x
Shih Kuen Plastics Co Ltd
TWO:4305
0.105x

Annual Cash Flow Conversion Efficiency for Laboratorios Richmond SACIF (2006–2024)

The table below shows the annual cash flow conversion efficiency of Laboratorios Richmond SACIF from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see Laboratorios Richmond SACIF stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 AR$65.35 Billion
≈ $47.29 Million
AR$5.62 Billion
≈ $4.07 Million
0.086x +194.63%
2023-12-31 AR$49.98 Billion
≈ $36.17 Million
AR$-4.54 Billion
≈ $-3.29 Million
-0.091x +78.32%
2022-12-31 AR$10.22 Billion
≈ $7.39 Million
AR$-4.29 Billion
≈ $-3.10 Million
-0.419x -131.00%
2021-12-31 AR$5.38 Billion
≈ $3.89 Million
AR$7.27 Billion
≈ $5.26 Million
1.353x +2622.42%
2020-12-31 AR$3.38 Billion
≈ $2.45 Million
AR$-181.33 Million
≈ $-131.21K
-0.054x -193.08%
2019-12-31 AR$2.10 Billion
≈ $1.52 Million
AR$121.02 Million
≈ $87.57K
0.058x +135.14%
2018-12-31 AR$1.11 Billion
≈ $803.87K
AR$-182.16 Million
≈ $-131.81K
-0.164x -1109.58%
2017-12-31 AR$688.05 Million
≈ $497.88K
AR$11.18 Million
≈ $8.09K
0.016x +183.82%
2016-12-31 AR$189.46 Million
≈ $137.09K
AR$-3.67 Million
≈ $-2.66K
-0.019x +92.67%
2015-12-31 AR$96.12 Million
≈ $69.55K
AR$-25.42 Million
≈ $-18.40K
-0.264x -477.45%
2011-12-31 AR$50.10 Million
≈ $36.26K
AR$3.51 Million
≈ $2.54K
0.070x -62.15%
2010-12-31 AR$44.82 Million
≈ $32.43K
AR$8.30 Million
≈ $6.00K
0.185x +694.54%
2009-12-31 AR$53.73 Million
≈ $38.88K
AR$1.25 Million
≈ $905.95
0.023x -95.41%
2007-12-31 AR$13.25 Million
≈ $9.59K
AR$6.73 Million
≈ $4.87K
0.508x -69.41%
2006-12-31 AR$7.75 Million
≈ $5.61K
AR$12.87 Million
≈ $9.31K
1.661x --

About Laboratorios Richmond SACIF

BA:RICH Argentina Drug Manufacturers - Specialty & Generic
Market Cap
$73.96 Million
AR$102.21 Billion ARS
Market Cap Rank
#20377 Global
#56 in Argentina
Share Price
AR$1535.00
Change (1 day)
+2.33%
52-Week Range
AR$970.00 - AR$2165.00
All Time High
AR$2165.00
About

Laboratorios Richmond S.A.C.I.F., a pharmaceutical company, develops and manufactures pharmaceutical products. It provides antiretroviral products for the treatment of human immunodeficiency virus (HIV); oncology and oncohematology drugs; cardiometabolic drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs … Read more